glp 1 and osteoporosis GLP-1 Use Associated with Lower Risk in Adults with Type 2 Diabetes but Higher Risk in Adults Without Diabetes The Impact of GLP1 Agonists

Glucagon-like peptide-1 receptor agonist (GLP-1RA) pharmaceutical interventions have advanced medical treatment for obesity, yet little is known about nutrient intake while using a GLP-1RA

All that follows is from the above resource

Trail registration Study registered in clinicaltrials.org with the identifier NCT05535322.

Pharmaceutical representative was part of a major announcement to make weight loss drugs more affordable

Full dose or microdose

Understanding the molecular processes involved in the development of diabetes and its debilitating vascular complications might bring up more effective and specific clinical therapies